Cubist pharmaceuticals stock
WebDec 8, 2014 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the companies have entered into a definitive agreement under which Merck will acquire … Web467037 (CBST) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed 467037 (CBST) YHD - YHD Delayed Price. Currency in USD Follow - (-) At close: …
Cubist pharmaceuticals stock
Did you know?
WebAccess our live streaming chart for the Cubist Pharmaceuticals Inc stock, free of charge. WebMar 28, 2024 · CUBIST PHARMACEUTICALS INC : Press releases relating to CUBIST PHARMACEUTICALS INC Investor relations Nasdaq: Nasdaq. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ 1 MarketScreener is worth more than 1000 Influencers! 100% Free Registration
WebApr 11, 2024 · In other Enanta Pharmaceuticals news, CEO Jay R. Luly sold 27,912 shares of the firm’s stock in a transaction on Monday, March 13th. The stock was sold at an average price of $45.16, for a total ... WebCubist Pharmaceuticals was an American biopharmaceutical company that targeted pathogens like MRSA. . The company employed 638 people, mostly in Lexington, MA. …
WebApr 6, 2024 · 14 brokers have issued 1 year price objectives for Apellis Pharmaceuticals' shares. Their APLS share price forecasts range from $40.00 to $139.00. On average, they predict the company's share price to reach $78.40 in the next twelve months. This suggests that the stock has a possible downside of 0.5%. WebThis Stock Option Agreement (the “Agreement”) governs an award (the “Award”) of stock options (“Stock Options”) to non-employee members of the Board of Directors of Cubist Pharmaceuticals, Inc. (the “Company”) who have been selected for participation (each such director, a “Participant”) under the Company’s 2014 Omnibus ...
WebSep 5, 2013 · Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced the pricing of $700 million aggregate principal amount of convertible senior unsecured notes that will be issued in two series, with one series of $300 million aggregate principal amount maturing on September 1, 2024 (the 2024 notes) and the other series of $400 million aggregate …
WebCubist Pharmaceuticals's latest funding round was a Acquired for on December 8, 2014. Cubist Pharmaceuticals's latest post-money valuation is from December 2014. Sign up for a free trial to see Cubist Pharmaceuticals's valuations in December 2014 and more. tsx bitcoinWebJan 21, 2015 · outstanding shares of common stock of Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) at a purchase price of $102.00 per share. As of the tender offer … tsx bitcoin stockWebApr 12, 2024 · Cubist Systematic Strategies LLC now owns 334,168 shares of the biopharmaceutical company’s stock valued at $4,662,000 after buying an additional 261,412 shares during the period. Hedge funds... tsx bitfWebJul 14, 2024 · Cubist Pharmaceuticals Inc (NASDAQ:CBST) released its quarterly earnings data on Tuesday, October, 21st. The biopharmaceutical company reported $0.58 … tsx bitcoin symbolWebMar 15, 2013 · This was an investigator-initiated study funded by Cubist Pharmaceuticals. We acknowledge John Paul McRoberts (Anti-Infective Research Laboratory, Wayne State University) for assistance in the extended microbiological assessment and verification. ... R.K. is now employed by Cubist Pharmaceuticals and owns Cubist Pharmaceuticals … tsx bloxWebDec 12, 2011 · Cubist Pharmaceuticals, Inc. today announced that it has completed the previously announced acquisition of Adolor Corporation for an aggregate upfront cash... April 10, 2024 phocas youtubeWebCubist Pharmaceuticals Price History Delisted . USA . . Cubist Pharmaceuticals Summary Forecast As of today, the current price of Cubist Pharmaceuticals is 0.00 , as … tsx bixenon headlights